H.R. 8964, titled 'Medical Records Access Fairness Act of 2024,' aims to amend the Health Information Technology for Economic and Clinical Health (HITECH) Act to allow individuals to obtain a copy of their protected health information at no cost, unless certain circumstances apply. ([govinfo.gov](https://www.govinfo.gov/app/details/BILLS-118hr8964ih?utm_source=openai))
While specific media coverage on H.R. 8964 is limited, the bill's provisions are likely to be viewed positively by patient advocacy groups and individuals seeking greater access to their medical records. By eliminating fees for obtaining personal health information, the bill could enhance transparency and empower patients to take a more active role in their healthcare decisions.
Although direct negative media coverage of H.R. 8964 is scarce, potential concerns may arise from healthcare providers and medical record custodians regarding the financial and administrative implications of providing free access to medical records. These stakeholders might argue that the bill could lead to increased operational costs and resource allocation challenges.
The bill H.R. 8964 aims to improve the safety of pasteurized donor human milk and enhance regulation, an area that does not have direct industry overlaps with the sponsor Rosa DeLauro's top donor industries, which include Health Professionals and Retired individuals. The total contributions from these donor categories amount to $105 million, with no specific ties to the donor human milk industry. This lack of direct connection suggests that there is minimal risk of conflicts of interest arising from the sponsor's financial backers. Additionally, while there are several lobbying activities in the policy area, the undisclosed amounts and lack of direct ties to the bill's subject matter further reduce the potential for conflicts. Voters should be aware that while lobbying exists, it does not directly implicate the sponsor's financial supporters in the bill's objectives.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| FRIENDS COMMITTEE ON NATIONAL LEGISLATION | FRIENDS COMMITTEE ON NATIONAL LEGISLATION | $1,000,000 |
| CEDIA | CEDIA | $120,000 |
| KNOA PHARMA LLC | MERCURY PUBLIC AFFAIRS, LLC | undisclosed |
| HELIX DEFENSE | CROSS POTOMAC CONSULTING LLC | undisclosed |
| SUR HOLDINGS | BGR GOVERNMENT AFFAIRS | undisclosed |
| GLOBAL KRATOM COALITION | BGR GOVERNMENT AFFAIRS | undisclosed |
| GIBSON, DUNN & CRUTCHER, LLP ON BEHALF OF CURATIVE INC. | BGR GOVERNMENT AFFAIRS | undisclosed |
| SEISMIC SOFTWARE, INC. | MILLER STRATEGIES, LLC | undisclosed |
| ALBERS AEROSPACE | BGR GOVERNMENT AFFAIRS | undisclosed |
| PALANTIR TECHNOLOGIES, INC. | AVOQ, LLC | undisclosed |
| RENAL CARE 360 | KILPATRICK TOWNSEND & STOCKTON | undisclosed |
| DEXCOM | BGR GOVERNMENT AFFAIRS | undisclosed |
| CITY OF PHILADELPHIA | BGR GOVERNMENT AFFAIRS | undisclosed |
| ORCA BIO | BGR GOVERNMENT AFFAIRS | undisclosed |
| IONQ, INC. | IONQ, INC. | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Rosa DeLauro, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
